Cardax Inc (CDXI) 0.0700 $CDXI
Cardax to Lead Aging Discussion at Chaminade University
BusinessWire - Tue Oct 06, 7:00AM CDT
Cardax, Inc. ("Cardax"
(OTCQB:CDXI) announced today that it will be leading a discussion on aging at Chaminade University's Public Policy Forum series on October 28, 2015.
Cardax Product Candidates Demonstrate Superior Bioavailability vs. Microalgal Astaxanthin in Monkey Study
BusinessWire - Wed Jul 29, 7:00AM CDT
Cardax, Inc. ("Cardax" (OTCQB:CDXI) announced today that its astaxanthin consumer health candidates CDX-085 and ASTX-1F demonstrated more than two and one-half times higher oral bioavailability than a leading microalgal astaxanthin product in a head-to-head monkey study. The study was conducted by top-tier contract research organizations and bioavailability was determined by measuring the plasma exposure of astaxanthin over four days following a single dose.
Cardax to Lead Aging Discussion at Chaminade University
BusinessWire - Tue Oct 06, 7:00AM CDT
Cardax, Inc. ("Cardax"
(OTCQB:CDXI) announced today that it will be leading a discussion on aging at Chaminade University's Public Policy Forum series on October 28, 2015. Cardax Product Candidates Demonstrate Superior Bioavailability vs. Microalgal Astaxanthin in Monkey Study
BusinessWire - Wed Jul 29, 7:00AM CDT
Cardax, Inc. ("Cardax"
(OTCQB:CDXI) announced today that its astaxanthin consumer health candidates CDX-085 and ASTX-1F demonstrated more than two and one-half times higher oral bioavailability than a leading microalgal astaxanthin product in a head-to-head monkey study. The study was conducted by top-tier contract research organizations and bioavailability was determined by measuring the plasma exposure of astaxanthin over four days following a single dose. 
